Sort
16,300 grants matching “fatty liver disease”
Endocannabinoids And Energy Homeostasis
$1,573,003George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
Interrupting the Vicious Cycle of Obesity and Metabolic Syndrome
$1,572,235Jacob E Friedman · University Of Colorado Denver · R24 · FY2017 · DK
New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders
$1,571,137Simon Vu · Equator Therapeutics, Inc. · R44 · FY2024 · DK
New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders
$1,571,137Simon Vu · Equator Therapeutics, Inc. · R44 · FY2025 · DK
Alcohol Center Of Research -- Nebraska (ACORN)
$1,569,501Carol A Casey · University Of Nebraska Medical Center · P50 · FY2023 · AA
Development of MR Based Biomarker Panels for NAFLD _ A NASH CRN Ancillary Study
$1,567,298Claude B Sirlin · University Of California, San Diego · R56 · FY2012 · DK
Building Access to Food through Systems and Solidarity
$1,566,126Stella S Yi · New York University School Of Medicine · R01 · FY2023 · MD
Ancillary Studies of NAFLD and NASH in HIV infected Adults
$1,566,039Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2021 · DK
Toxic lipid intermediate accumulation and cobalamin depletion promote AHR-mediated hepatotoxicity and the progression of non-alcoholic fatty liver disease (NAFLD)-like pathologies
$1,565,100Timothy R Zacharewski · Michigan State University · R01 · FY2022 · ES
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome
$1,562,834Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2022 · CA
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome
$1,562,554Hashem B El-Serag · Baylor College Of Medicine · P01 · FY2025 · CA
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center
$1,562,234James A Tonascia · Johns Hopkins University · U24 · FY2023 · DK
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection
$1,561,914Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2024 · TR
Ancillary Studies of NAFLD and NASH in HIV infected Adults
$1,558,981Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2022 · DK
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center
$1,554,043David M Shade · Johns Hopkins University · U24 · FY2024 · DK
Interventions Testing Program at UM
$1,553,900Richard A. Miller · University Of Michigan At Ann Arbor · U01 · FY2024 · AG
Endocannabinoids And Energy Homeostasis
$1,553,521George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Reversible Mitochondrial Protein Acetylation and Metabolic Regulation
$1,550,605Eric M Verdin · J. David Gladstone Institutes · R24 · FY2016 · DK
SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT
$1,550,492Alan R Kimmel · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Establishing patient-derived iPSCs as a platform for discovery research in NAFLD
$1,550,397Jacquelyn J. Maher · University Of California, San Francisco · RC2 · FY2024 · DK
Regulation of hepatic and systemic immune responses
$1,550,275Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Sirtuins and nuclear receptors in aging and age-associated diseases
$1,549,637Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
The Southern California Research Center for ALPD and Cirrhosis
$1,549,231Hidekazu Tsukamoto · University Of Southern California · P50 · FY2019 · AA
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center
$1,547,234James A Tonascia · Johns Hopkins University · U24 · FY2022 · DK
Human Energy and Body Weight Regulation Core
$1,546,870Kong Chen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2024 · DK